UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043812
Receipt number R000050010
Scientific Title Usefulness of PFC-FD in cases of implantation failure associated with endometrial thinning
Date of disclosure of the study information 2021/04/05
Last modified on 2023/10/02 11:55:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Usefulness of PFC-FD in cases of implantation failure associated with endometrial thinning

Acronym

Study on the usefulness of PFC-FD

Scientific Title

Usefulness of PFC-FD in cases of implantation failure associated with endometrial thinning

Scientific Title:Acronym

Study on the usefulness of PFC-FD

Region

Japan


Condition

Condition

endometrial thinning,recurret implantation failure

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate effecttive of uterine infusion of PFC-FD on endometrial thinning,recurret implantation failure.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

pregnancy rate

Key secondary outcomes

Endometrial thickness, fertility rate, and abortion rate


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Intra-uterine injection of PFC-FD

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

50 years-old >

Gender

Female

Key inclusion criteria

mplantation failure more than three times,
less than 8.0 mm of endometrium at the time of implantation

Key exclusion criteria

autoimmune disorders, sexually transmitted diseases, infectious diseases,
tubal factor infertility/tubal obstruction, chronic inflammatory diseases, endometriosis, chronic
endometritis, and endocrine disorders such as thyroid dysfunction,were excluded in general.
Body Mass Index (BMI) above 30 or less than 18.5, hypothalamic-pituitary disorders

Target sample size

100


Research contact person

Name of lead principal investigator

1st name DAISUKE
Middle name
Last name KADOGAMI

Organization

IVF Namba Clinic

Division name

medical office

Zip code

5500015

Address

1-17-28 Minamihorie Nishi-ku Osaka JAPAN

TEL

0665348824

Email

kadogami515@ivfjapan.com


Public contact

Name of contact person

1st name DAISUKE
Middle name
Last name KADOGAMI

Organization

IVF Namba Clinic

Division name

Doctor

Zip code

5500015

Address

1-17-28 Minamihorie Nishi-ku Osaka JAPAN

TEL

0665348824

Homepage URL


Email

kadogami515@ivfjapan.com


Sponsor or person

Institute

IVF Namba Clinic

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IVF JAPAN

Address

1-17-28 Minamihorie Nishi-ku Osaka JAPAN

Tel

0665348824

Email

kadogami515@ivfjapan.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 04 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 04 Month 05 Day

Date of IRB

2021 Year 04 Month 21 Day

Anticipated trial start date

2021 Year 04 Month 12 Day

Last follow-up date

2021 Year 04 Month 12 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 04 Month 01 Day

Last modified on

2023 Year 10 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050010


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name